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866Disarticulation of the knee: Analysis of an extended
database on survival, wound healing, and ambulationRachelle Nijmeijer, BSc,a Henricus G. J. M. Voesten, MD,b Joannes H. B. Geertzen, MD, PhD,a and
Pieter U. Dijkstra, PhD,a,c Groningen and Drachten, The NetherlandsABSTRACT
Objective: This study analyzed survival of the amputee patients, wound healing, and ambulation after knee disarticu-
lation (KD).
Methods: Between July 1989 and October 2015, 153 KDs in 138 patients were performed at Nij Smellinghe Hospital,
Drachten. Data were retrieved from hospital medical records. Wound healing was analyzed using nonparametric tests.
Ambulation was recorded according to the Special Interest Group Amputation Medicine Workgroup Amputation and
Prosthetics mobility scale.
Results: Survival at 1, 6, and 12 months was 86%, 65%, and 55%, respectively. Wounds healed in 91% of patients. Wounds
healed primarily in 57% of residual limbs, and healing was delayed in 33%. A transfemoral amputation (TFA) was per-
formed in 10%. Patients with sagittal ﬂaps had signiﬁcantly poorer primary wound healing and delayed wound healing
more often than patients with a dorsal-myocutaneous (dorsomyocutaneous) ﬂap (P < .027). In total, 62% of patients were
provided with a prosthesis. Preoperatively, 71% of the patients had intention to ambulate with prosthesis, of which 91%
received prosthesis. Of these, 35% walked without the help of others. KD amputee patients who underwent a ream-
putation at the transfemoral level were signiﬁcantly less ambulant than amputee patients who did not (P < .021).
Conclusions: If feasible, the dorsomyocutaneous ﬂap technique seems to be the treatment of choice in KD. Because the
wound complication rate of the group with a dorsomyocutaneous ﬂap and the percentage of amputee patients who
received prosthesis after KD fell within the same range as TFA amputee patients, KD may be an appropriate alternative
when surgeons consider a TFA. (J Vasc Surg 2017;66:866-74.)Each year, w3300 major lower limb amputations are
performed in The Netherlands.1 Whenever a transtibial
amputation (TTA) is not feasible, a more proximal knee
disarticulation (KD) or transfemoral (TF) amputation
(TFA) should be considered.2 In contrast to TFA, KD offers
several advantages. Surgically, KD is simple, quick to
perform, and less traumatic because no bone has to be
dissected.3 Clinically, the most important advantages of
a KD is less energy consumption during walking and
the potential for direct load transfer to the residual
limb compared with TFA.4,5 Surgeons often avoid KDs
because of assumed wound healing complications and
poor prosthetic ﬁtting skills.6,7 These arguments mighte Department of Rehabilitation Medicinea and Department of Oral and
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x.doi.org/10.1016/j.jvs.2017.04.052be no longer relevant because surgical techniques and
prosthesis technology have improved considerably.4
In an effort to minimize the disadvantages of KD,
several modiﬁcations with a variety of surgical ﬂap de-
signs have been devised.8 Instead of a long anterior
ﬂap used previously, sagittal ﬂaps have been promoted
(Fig 1).7 The beneﬁt of this technique is that shorter tissue
ﬂaps are necessary to close the wound, resulting in
improved wound healing.6 However, these ﬂaps are
rather thin, consist of only skin and subcutaneous tissue,
and have been dissected with loss of blood vessels pene-
trating this fascia.9
A long dorsal-myocutaneous (dorsomyocutaneous) ﬂap
was introduced (Fig 2) in 1985.9,10 This ﬂap includes
gastrocnemius muscle bellies and posterior calf skin
with preservation of perforating vessels. It provides excel-
lent padding and blood supply, seems to prevent ﬂap ne-
crosis, and is comfortable for prosthetic rehabilitation
because of the thick and mobile distal ﬂap.7,9
Whether these developments in surgical ﬂap designs
have resulted in improved survival, wound healing, and
ambulation in KD amputee patients is unknown. When
combined with modern polycentric prosthetic joints,
KD can offer improved walking stability in the geriatric
population, enabling the performance of activities of
daily living and thereby independence and a better
quality of life.11-13
The aim of this study was to analyze survival of the
amputee patient, wound healing, and ambulation after
KD with preservation of the femoral condyles in patients
ARTICLE HIGHLIGHTS
d Type of Research: Single-center retrospective cohort
study
d Take Home Message: In 115 early survivors of knee
disarticulation (KD), primary wound healing with
dorsomyocutaneous ﬂaps was 85%, signiﬁcantly
higher than in those with sagittal ﬂaps (53%). Sixty-
two percent received prosthesis, and 35% walked
independently after KD.
d Recommendation: This study suggests KD with dor-
somyocutaneous ﬂap closure as a good alternative
to transfemoral amputation for selected patients.
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Volume 66, Number 3with peripheral arterial disease (PAD). Outcomes of this
study may provide new insights in the determination of
indication criteria for KD.
METHODS
This study was a retrospective cohort study at Nij Smell-
inghe Hospital, Drachten, The Netherlands, and was
approved by the Medical Ethics Committee (ref: NH/SP/
15-0827). Between July 1985 and October 2015, 385 major
lower limb amputations in 329 patients were performed
at Nij Smellinghe Hospital. The study included all pa-
tients who underwent a KD, leaving 138 patients with
153 KDs for analysis. No patient informed consent was ob-
tained. There were no exclusion criteria. One surgeon
(H.V.) performed 94% of these amputations. Outcome
variables were survival of the amputee patient, wound
healing, and ambulation after KD in patients predomi-
nantly with PAD.
Date of the KD procedure was recorded from the surgi-
cal procedure report. Date of death was veriﬁed using
the hospital’s computerized medical record. Data
regarding patient characteristics, reason for KD, previous
ipsilateral revascularization procedures, other (bilateral)
amputation procedures, concomitant diseases, smoking,
and wound healing were retrieved frommedical records.
Most of the data were gathered from the software pro-
gram used at the hospital. Other data, generally before
2000, were retrieved from paper medical records from
the archive.
Patient characteristics included gender and date of
birth. The reason for KD was categorized into acute or
chronic vascular disease and infection. Previous ipsilat-
eral revascularization procedures, a previous ipsilateral
TTA, a reamputation at the TF level, and other bilateral
amputation procedures starting from TTA were regis-
tered, including date of the procedure.
Wound healing was categorized into primary wound
healing, delayed wound healing, or complicated wound
healing resulting in TFA. Primary wound healing
included wounds of which the stitches could be
removed after 3 weeks without problems. Delayed
wound healing included wound infection, proven by
positive wound cultures and use of antibiotics. Compli-
cated wound healing included an open wound 3 weeks
after amputation, making other measures such as
vacuum-assisted closure and reamputation at TF level
necessary.
The following comorbidities were included for analysis:
PAD, diabetes mellitus, cardiovascular disease, renal fail-
ure, cerebrovascular disease, chronic obstructive pulmo-
nary disease (Global Initiative for Chronic Obstructive
Lung Disease stage III or IV), and rheumatism. Whether
a patient was suffering from comorbidity was retrieved
from medical records. In case of unclear descriptions,
the attending surgeon (H.V.) decided the type of comor-
bidity based on description of signs and symptoms anddiagnostic outcomes. Smoking was categorized as
smoker, nonsmoker, or former smoker.
Data concerning prosthetic ﬁtting and ambulation
were retrieved from medical records of the hospital
and the rehabilitation physician. Three variables were
recorded: whether the patient received a functional pros-
thesis, whether there was (preoperative) intention for
prosthesis use, and the Special Interest Group Amputa-
tion Medicine Workgroup Amputation and Prosthetics
(SIGAM-WAP) mobility score, which assesses mobility
with leg prosthesis.14 The SIGAM-WAP score was used
to categorize patients into ﬁve scales: Scale A includes
patients who did not receive prosthesis, do not use their
prosthesis, or use their prosthesis only ornamentally.
Scale B includes patients who received a prosthesis but
only use the prosthesis for transfer or to assist in care or
walk only with the help of others or during exercise ther-
apy. Scale C includes patients who only walk on ﬂat sur-
face or <50 meters, with or without the help of a walking
aid. Scale D includes patients who walk >50 meters, only
on ﬂat surface and in good weather, with or without
walking aids. Scale E includes patients who walk
>50meters, without walking aid or just to be sure, on un-
even or slippery terrain.
Statistical analysis. The data were analyzed using SPSS
23 software (IBM Corp, Armonk, NY). P # .05 was consid-
ered as statistically signiﬁcant.
Patient survival at 1, 6, and 12 months was analyzed in a
Kaplan-Meier curve. If the patient was still alive, the date
of the ﬁrst analysis of this study (January 20, 2016) was
used to analyze the survival. In bilateral KD amputee
patients, the ﬁrst amputation was included for analysis.
If the date of the KD amputations was the same, the ﬁrst
amputation in the database was included. Difference in
survival between unilateral and bilateral KD amputee
patients, patients whose amputation occurred between
July 1989 to March 2006, and April 2006 to October
2015, and patients with a previous ipsilateral TTA, a ream-
putation at the TF level, or no other ipsilateral amputa-
tion were also analyzed using a log-rank test. Data of
Fig 1. Sagittal ﬂaps: Equal and short ﬂaps.
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Smellinghe Hospital have been published previously.2
The overall wound healing analysis was performed per
residual limb. This analysis excluded data of 27 patients
who died #1 month or before leaving the hospital.
Differences in wound healing were analyzed using the
Mann-Whitney U test and the Kruskal-Wallis test. These
analyses were performed per patient, instead of per
residual limb, to avoid concomitant diseases being
included twice.In the prosthesis ﬁtting and SIGAM-WAP analysis, the
maximum level achieved after KD was registered for
both unilateral and bilateral patients. Ambulation was
categorized into the highest SIGAM-WAP level recorded.
The following patients were excluded from analyses of
discharge destination and ambulation, including pros-
thesis ﬁtting and SIGAM-WAP scores: patients who died
during the hospitalization or #1 month after amputation
(n ¼ 23), who underwent a reamputation at the TF level
(n ¼ 12), and of whom the only known data were whether
Fig 2. The dorsomyocutaneous ﬂap includes gastrocnemius muscle bellies and posterior calf skin as a com-
bined ﬂap, without destruction of the perforating vessels.
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with a prosthesis (n ¼ 7). Data of 10 patients were incom-
plete. The difference in ambulation between patients
who did and did not undergo a bilateral amputation
and between patients who did and did not undergo a
reamputation at the TF level were analyzed using the
Mann-Whitney U test.RESULTS
In total, 145 TTA, 153 KD, and 87 TFA were performed. Of
the KD amputee patients, 57 were women (41%). The
mean age at time of amputation was 74.2 6 12.7 years.
The median age of women (79.0 years; interquarticle
range [IQR], 69.5-84.0 years) was older than the median
age of men (75.0 years; IQR, 68.0-80.0 years; P ¼ .048).




#74.2 years 41.3 (57/138)







Cardiovascular disease 62.2 (79/127)
Renal failure 46.9 (61/130)




#3 comorbidities 57.2 (79/138)




Former smoker 15.5 (15/97)
Previous ipsilateral procedures
Revascularization 32.6 (45/138)
Transtibial amputation 8.7 (12/138)
Reason for amputation









No wound healing resulting in TFA 9.5 (12/126)
Postoperative stump dressing
Elastic bandage 63.4 (97/153)
Plaster of Paris 36.6 (56/153)
Discharge destination
Nursing facility 60.0 (81/135)
Rehabilitation center 16.3 (22/135)
Rehabilitation day care 5.9 (8/135)
Home 4.4 (6/135)
Died in hospital 13.3 (18/135)
Discharged KD amputee patients
Provided with prosthesis 61.6 (53/86)





Scale A 39.5 (34/86)
Scale B 25.6 (22/86)
Scale C 24.4 (21/86)
Scale D 5.8 (5/86)
Scale E 4.9 (4/86)
COPD, Chronic obstructive pulmonary disease; DM, diabetes mellitus;
PAD, peripheral arterial disease; SIGAM-WAP, Special Interest Group
Amputation Medicine Workgroup Amputation and Prosthetics; TFA,
transfemoral amputation.
an/N ¼ observed frequency/number of available data.
bThe percentages >100% because of rounding.
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amputation in 96% of patients (Table I), and 95% of these
patients had gangrene. Nearly all patients had PAD
(98%). The median follow-up was 1.0 year (IQR, 0.2-
3.8 years) and the median hospitalization time was
25.0 days (IQR, 12.0-51.5 days).
Survival at 1, 6, and 12 months was 86%, 65%, and 55%,
respectively (Fig 3). After patients who died early were
excluded, a data set of 115 patients with 126 residual
limbs was available for analysis. Of these residual limbs,
72 wounds (57%) healed primarily and 42 wounds
(33%) had delayed healing (Table I). Complete wound
healing occurred in 114 wounds (90%). Wound healing
in 12 residual limbs (10%) was complicated and TFA
was performed. The median interval between KD and
reamputation at the TF level was 1.1 months (IQR,
0.7-2.7 months). A prothesis was received by 55% of the
patients with delayed wound healing and by 66% with
primary wound healing.
Only the type of incision was signiﬁcantly associated
with wound healing problems (Table II). Primary wound
healing was signiﬁcantly poorer in patients with sagittal
ﬂaps (53%) than in patients with a dorsomyocutaneous
ﬂap (85%). There was no signiﬁcant difference in survival
between patients with a unilateral or bilateral KD
(P ¼ .391), between patients whose amputation occurred
between July 1989 to March 2006 and April 2006 to
October 2015 (P ¼ .410), or between patients with a pre-
vious ipsilateral TTA, a reamputation at the TF level, or
in whom no other ipsilateral amputation was found
(P ¼ .680).
After the exclusion of patients who died during hospi-
talization or #1 month after amputation, who underwent
a reamputation at TF level, or those with missing data on
preoperative intention to walk with prosthesis, a data set
of 96 patients was available for analysis of discharge
destination, prosthesis ﬁtting, and SIGAM-WAP (Table I).
Of these 96 patients, 86 had complete data sets and 53
(62%) were provided with a prosthesis. Preoperatively,
71% (58 of 82) of the patients had intention to ambulate
Fig 3. Overall survival after knee disarticulation (KD) in
months based on data of 134 patients. Data for four
patients were incomplete.
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thesis. Of patients with sagittal ﬂaps, 63% received
prosthesis, while 50% of the patients with a dorsomyocu-
taneous ﬂap received prosthesis. Of the 86 patients, 35%
(n ¼ 30) were classiﬁed into scale C or higher of the
SIGAM-WAP scale. The amputations were bilateral in 33
patients (24%): 9 patients at the TTA level, 15 at the KD
level, and 9 at the TF level. Patients who underwent a
reamputation at the TF level were classiﬁed signiﬁcantly
lower on SIGAM-WAP scale than those without reampu-
tation (Table III).
DISCUSSION
A review involving KD found primary healing ranged
between 60% and 100%, delayed healing between 0%
and 26%, and reamputation between 0% and 21%.7 In
our study, primary and delayed wound healing of pa-
tients with a dorsomyocutaneous ﬂap was similar, but
wound healing in patients who received sagittal ﬂaps
was less favorable.
In the dorsomyocutaneous ﬂap technique, a transverse
incision is made cranially to the tuberositas tibiae, basi-
cally imitating an extremely short TTA incision. Length
of the patellar ligament was preserved by cutting this
at its distal end. By going straight through the cruciate
and collateral ligaments, the knee joint opens up and
the complete soft tissue covering at the back of the tibia
and ﬁbula is removed, preserving the blood supply. The
length of the ﬂap is determined by how thick the
gastrocnemius muscle bellies are. In most cases,
removing the soleus muscle is enough to allow for
closure without tension.
Whether the differences in wound healing in our study
can be solely attributed to the type of incision is unclear.
Sagittal ﬂaps were ﬁrst used in 1989, initially in emer-
gency cases for life saving, speed of surgery, and minimal
blood loss. The appearance of pressure ulcers at thefemur condyles in high-risk patients made it necessary
to look for a more bulky cover, and the dorsomyocutane-
ous technique was introduced in 2008. The skills of the
surgeon may have developed as he gained experience
over time. Prosthetics did not result in more pressure
sores and wound complications for the two ﬂaps
because a prosthesis was not measured until complete
wound healing had occurred.
The ambulation rate for KD amputee patients in a sys-
tematic review ranged from 13% to 75%.7 The prosthetic
ambulation rates in two retrospective studies evaluating
sagittal ﬂaps were 31% and 53%, and the rate of one
retrospective study evaluating a dorsomyocutaneous
ﬂap was 75%. Our rate of 62% fell within the same range
compared with these percentages. However, 63% of
the patients in our study with sagittal ﬂaps received
prostheses, whereas 50% of the patients with a dorso-
myocutaneous ﬂap received prostheses. Prosthetic
rehabilitation in patients with a dorsomyocutaneous
ﬂap was expected to be higher because of the thick
and mobile distal ﬂap.9 This result might be related to
the small group of patients with a dorsomyocutaneous
ﬂap.
In the literature, 30-day survival of TFA patients ranged
between 73% and 90% and 1-year survival between 42%
and 69%.11,15-17 Our survival data fell within the same
range. A retrospective study found a higher survival rate
for TTA than for TFA.18 Patients who underwent TTA
may have had a better health at time of the amputation
than patients who underwent KD or TFA. When TTA is no
longer feasible and the choice has to be made between
KD or TFA, the patient’s physical condition might be
already worse, resulting in similar survival rates for KD
and TFA.
Patients who died #1 month or before leaving the hos-
pital were excluded from wound healing analysis
because the patient’s condition could have affected
wound healing too much and the period of time to
death was too short to assess actual wound healing. In
the literature, the wound complication rate after TFA
ranged between 7% and 29%, and the reoperation rate
(including reamputation) after TFA ranged between 0%
and 12%.16,17,19,20 In our study, delayed wound healing
appearedmore often after KD than after TFA, as reported
in literature. This difference may be attributed to the
numerous sagittal ﬂaps in our study. The complication
rate of the group with dorsomyocutaneous ﬂaps fell
within the same range as the complication rate after
TFA. The reamputation rate of all KD amputees in this
study also fell within the same range as the reoperation
rate after TFA. Because use of a dorsomyocutaneous
ﬂap indicated positive wound healing outcomes, further
research concerning KDs with a dorsomyocutaneous ﬂap
is recommended. KD is not advisable in patients with
extreme cachexia or purulent septic arthritis and in
case of poor skin quality of <7 cm below the knee joint.
Table II. Analysis of differences in wound healing between different groupsa
Variables
Wound healing
No.b U value P valuePrimary, % Delayed, % Reamputation TFA, %
Unilateral 58.4 30.7 10.9 101 620.00 .400
Bilateral 42.9 50.0 7.1 14
DM
Yes 50.0 40.5 9.5 42 1401.50 .388
No 60.3 28.8 11.0 73
Cardiovascular disease
Yes 56.4 33.3 10.3 39 1269.50 .782
No 58.2 34.3 7.5 67
Renal failure
Yes 59.7 35.5 4.8 62 1292.50 .460
No 55.6 31.1 13.3 45
Cerebrovascular disease
Yes 55.3 38.2 6.6 76 1458.00 .873
No 59.0 23.1 17.9 39
COPD
Yes 59.4 32.3 8.3 96 459.00 .419
No 45.5 45.5 9.1 11
Rheumatism
Yes 58.8 32.4 8.8 102 148.50 .294
No 25.0 75.0 0.0 4
Concomitant diseases
#3 55.7 34.3 10.0 70 1553.50 .889
$4 57.8 31.1 11.1 45
Age, years
#74.2 53.2 34.0 12.8 47 1490.00 .487
>74.2 58.8 32.4 8.8 68
Flap
Sagittal 52.9 35.3 11.8 102 441.00 .027
Dorsomyocutaneous 84.6 15.4 0.0 13
Elastic bandage 58.3 29.2 12.5 72 1518.00 .845
Plaster of Paris 53.5 39.5 7.0 43
Smoker 48.7 38.5 12.8 39 4.190 .123
Nonsmoker 57.6 33.3 9.1 33
Former smoker 78.6 21.4 0.0 14
COPD, Chronic obstructive pulmonary disease; DM, diabetes mellitus; TFA, transfemoral amputation.
aAll analyses were Mann-Whitney U tests, except in the analysis of smoking, for which a Kruskal-Wallis test was performed.
bBecause of incomplete data, the number of available observations is reported.
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September 2017However, if a spacer is used in a failed knee joint removal
and a second joint replacement or a knee arthrodesis is
not feasible, KD is still possible.
A systemic review revealed that there was progressive,
signiﬁcant reduction of ambulation as unilateral ampu-
tation height became more proximal from TTA to KD
and TFA.21 For that reason, data were excluded from
the ambulation analysis if a patient underwent a ream-
putation at the TF level. Some patients (n ¼ 34) might
have been more ambulant than registered, but follow-
up data were not available. These patients were classiﬁedinto the highest known SIGAM-WAP scale. The likelihood
of or the actual receipt of a prosthesis after TFA ranged
between 29% and 70%.16,22 Approximately 20% of the
TF amputee patients walked postoperatively, with or
without the help of a walking aid.23,24 In our study, 62%
of the KD amputee patients received a prosthesis, and
35% walked without the help of others. KD amputee pa-
tients appeared to be more ambulant postoperatively
than those who underwent (re-)amputation at the TF
level. This result was expected given the theoretical ad-
vantages of a KD.
Table III. Differences in ambulation between groups
Variable
SIGAM-WAP mobility scale
No.a U valueb P valueA, % B, % C, % D, % E, %
Bilateral amputation
Yes 44.0 32.0 24.0 0.0 0.0 25 633.50 .198
No 37.7 23.0 24.6 8.2 6.6 61
Reamputation TFA
Yes 88.9 0.0 0.0 11.1 0.0 9 215.50 .021
No 39.5 25.6 24.4 5.8 4.7 86
SIGAM-WAP, Special Interest Group Amputation Medicine Workgroup Amputation and Prosthetics; TFA, transfemoral amputation.
aBecause of incomplete data, the number of available observations is reported.
bResults of Mann-Whitney U test.
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Volume 66, Number 3The strength of this study was that almost all of the 153
KDs in 138 patients in the past 27 years were performed
by a single vascular surgeon in the northern part of The
Netherlands. A comparison of our data with results of
TFAs, as described in literature, was hampered because
studies presented results in a slightly different way. We
did not record quality of life after KD. Whether retaining
the knee joint provides a patient a higher quality of life is
indistinct. Although most surgeons might assume that
outcomes are better after KD than after TFA as a result
of greater ambulation with more independence, further
research regarding quality of life after lower limb ampu-
tation is necessary.
CONCLUSIONS
If feasible, the dorsomyocutaneous ﬂap technique
seems to be the treatment of choice in KD compared
with the sagittal ﬂap technique. Because the wound
complication rate of the group with a dorsomyocutane-
ous ﬂap and the percentage of KD amputee patients
who received a prosthesis fell within the same range as
the TFA amputee patients, KD may be an appropriate
alternative when surgeons consider a TFA.
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